Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H2 2017

Industry: 

580 Views
Buy This Report

Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Bile Duct Cancer (Cholangiocarcinoma) (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

  • 580 reads